Europas första cannabisbolag på börsen noteras i Sverige

Stenocare tar in pengar och ska lista sig på First North

Visiting address: Strandbergsgatan 55, in Stockholm Citycon Oyj's shares are listed on the Nasdaq Helsinki. The company has one series of shares. Each share carries one vote at the general meeting of shareholders and confers an equal right to a dividend. The company is listed in Denmark and among the 25 most traded shares on Nasdaq Copenhagen.

View real-time stock prices and stock quotes for a full financial overview. Shares in Stenocare A/S are currently trading at DKK16.44 and the price has moved by 23.81% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Stenocare A/S price has moved by -14.34% over the past year. 2021-04-07 How has Stenocare's share price performed over time and what events caused price changes?

For each 6 rights it is possible to purchase one New Share in the issue and for each 3 New Shares purchased in the issue, ONE free share is delivered by the Founders. Therefore, as an example, for each 18 shares held, 3 new shares can be purchased at the price of 20dkk each. This way the shareholder has 21 shares.

Stenocare Forum Placera

juni 2020 Danske STENOCARE A/S dyrker, importerer og sælger receptpligtig medicinsk cannabis. Selskabet vil hente op til DKK 45 mio. på deres fortegningsemission på Nasdaq First North i Danmark til en pre-money værdi på ca. DKK 179 mio.

STENOCARE: Idag inleds handeln i STENOCARE A/S aktier

STENOCARE kommer även att utveckla en separat produktionsanläggning för odling och produktion av egna medicinska cannabisprodukter i Bolagets lokaler på Jylland i Danmark. Find the latest historical data for Stenocare AS (STEOF) at Nasdaq.com. Skip to main content. Market Activity. CLOSE Get up to 10 years of daily historical stock prices & volumes. Copenhagen, May 18, 2020 - Nasdaq (Nasdaq: NDAQ) announces that trading in the STENOCARE A/S share (short name: STENO starts today on Nasdaq First North Growth Market Denmark.

The Companyâ€™s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. Stock analysis for Stenocare A/S (STEOF) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get Stenocare A/S (STENO-DK:Copenhagen Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. STENOCARE A/S is a Denmark-based company, which is engaged in the production of medical cannabis products to patients. The Companyâ€™s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic.
Svensk fast huvudkontor

It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. Stenocare AS is a Danish company engaged in the development, imports and marketing of medical cannabis products through pharmacies and hospitals. The company's product offering includes medical cannabis oil under the name CBD DROPS STENOCARE, 1: 1 DROPS STENOCARE, and THC DROPS STENOCARE. STENOCARE har valgt at stoppe med import og distribution af vores tre Medicinsk cannabis olie-produkter ”STENOCARE DROPS”. Årsagen er, at leverandøren af produkterne har en igangværende sag med de Canadiske myndigheder, fordi de har anvendt dyrkningsrum til produktionen, som ikke havde fået endelig godkendelse til at blive anvendt. StenoCare’s stock nearly quadrupled in price to hit a high of 33.50 Danish crowns in early trade, valuing the company at more than 200 million crowns ($30 million). They had been priced at 8.80 Today, 27 May 2020, marks the first day of subscribing for the STENOCARE share issue on Nasdaq First North Growth Market Denmark.

Historical data. Rank by performance. De senaste tweetarna från @sharenewsjapan1 : Get the latest Chordate Medical stock price and detailed information including news, historical charts and realtime prices. Headquarters. Postal address: P.O. Box 30174 SE-104 25 Stockholm. Visiting address: Strandbergsgatan 55, in Stockholm Citycon Oyj's shares are listed on the Nasdaq Helsinki. The company has one series of shares.
Bilparkering tecknad

A wealth of information on shares: share prices, research, charts, share news and more across a range of equities from Hargreaves Lansdown. 2020-06-16 Today, 27 May 2020, marks the first day of subscribing for the STENOCARE share issue on Nasdaq First North Growth Market Denmark. New investors and existing shareholders are given a unique offering to subscribe for 3 New Shares at DKK 20 per share and get 1 free bonus share. This offer equals an average price of DKK 15 per share STENOCARE completed a 29.8mDKK public Rights Issue with 58% being pre-subscribed and an oversubscription allocation of 15mdkk (additional). The Rights Issue received subscriptions for 117mDKK or 392%. The remaining 42% (or about 12.5mDKK) that was available for public subscription, 2021-04-09 Danish cannabis firm StenoCare shares surge on debut.

Köp aktier i STENOCARE - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. The listing on Spotlight Stock Market has been preceded by a new share issue that provided STENOCARE approx. DKK 18.6 million before LEI: 549300NCH67H3GA28R82 Last day of trading at Spotlight: May 15, 2020. Stockholm May 13, 2020.
Log flume ride

Handelsstopp STENOCARE A/S aktie - Spotlight Stock Market

Following up on their promise given on January 14, 2020, the founders of STENOCARE announce that they will deliver free shares to all subscribers in STENOCARE's upcoming Rights Issue corresponding Buy 3 New Shares at DKK 20 per share and get 1 free bonus share from the STENOCARE Founders. This offer is equal to an average price of DKK 15 per share. The share issue is a “Rights Issue” and gives priority to existing shareholders and owners of subscription rights. 2020-05-22 Following up on their promise given on January 14, 2020, the founders of STENOCARE announce that they will deliver free shares to all subscribers in STENOCARE’s upcoming Rights Issue corresponding to a total value of about 20mDKK and corresponding to an instant value increase in the share of about 5%. 2020-05-27 13:31:28 STENOCARE - Today is the first day of subscribing for the share issue-0,32% | 1,37 MDKK 2020-05-18 09:54:50 STENOCARE: I dag er første handelsdag på Nasdaq First North Growth Market Denmark +25,67% | 4,10 MDKK 2021-02-27 2021-03-04 StenoCare, founded last year by CEO Thomas Skovlund Schnegelsberg and Chief Operating Officer Soren Kjaer, priced its IPO at 8.80 crowns per share, valuing the company at 59.7 million crowns.